Gilead Sciences
GILD
#96
Rank
A$280.09 B
Marketcap
A$225.89
Share price
0.08%
Change (1 day)
26.19%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2026 (TTM): A-$3.52

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is A-$3.69. In 2025 the company made an earnings per share (EPS) of A$9.72 an increase over its 2024 EPS that were of A$0.54.

EPS history for Gilead Sciences from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$3.52-136.21%
2025A$9.721702.63%
2024A$0.54-91.65%
2023A$6.4623.98%
2022A$5.21-25.86%
2021A$7.024850%
2020A$0.14-97.64%
2019A$6.020.9%
2018A$5.9618.71%
2017A$5.02-64.88%
2016A$14.30-18.45%
2015A$17.5455.28%
2014A$11.29296.02%
2013A$2.8517.89%
2012A$2.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.39-435.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$1.08-129.23%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$5.07-237.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$42.40-1,249.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$23.01-723.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$8.06-318.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$7.68-308.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$24.59-766.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.80-148.67%๐Ÿ‡บ๐Ÿ‡ธ USA